| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GRF.MC - Grifols SA | BUY | 4,988 @ EUR 10.08 | EUR 50,279 |
Deprecated: number_format(): Passing null to parameter #1 ($num) of type float is deprecated in /var/www/liquidata/show_ETF_trades.php on line 94
The ETF bought 4988 new shares of GRF.MC (Grifols SA). The shares were bought for an average price of 10.08 compared to the previous average buy price of . This is 0.0% than average price of previous purchases of GRF.MC. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 118.3 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 118.3. The average price that BIM.PA shares were previous bought at was EUR 110.633. The current market price is 6.9% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 4,946 (USD $5,631) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 192.834 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 192.834. The average price that GMAB.CO shares were previous bought at was DKK 190.425. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 120,820 (USD $18,441) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 113.837 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 113.837. The average price that STMN.SW shares were previous bought at was CHF 118.249. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 83,296 (USD $101,224) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 285.609 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 285.609. The average price that ROG.SW shares were previous bought at was CHF 285.605. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,207,512 (USD $1,467,404) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 305.704 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 305.704. The average price that RO.SW shares were previous bought at was CHF 302.302. The current market price is 1.1% higher than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 79,980 (USD $97,194) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 49.82 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 49.82. The average price that FME.DE shares were previous bought at was EUR 46.8565. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 19,180 (USD $21,835) compared to the previous valuation of Fresenius Medical Care AG |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 57.46 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 57.46. The average price that ERF.PA shares were previous bought at was EUR 51.0554. The current market price is 12.5% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 14,074 (USD $16,022) compared to the previous valuation of Eurofins Scientific SE |
| GALD.SW - | HOLD | 0 @ CHF 120.251 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 120.251. The average price that GALD.SW shares were previous bought at was CHF 104.269. The current market price is 15.3% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 49,272 (USD $59,877) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 61.5 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 61.5. The average price that ORNBV.HE shares were previous bought at was EUR 50.7131. The current market price is 21.3% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 19,303 (USD $21,975) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 12.8549 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 12.8549. The average price that SN.L shares were previous bought at was GBP 12.775. The current market price is 0.6% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 1,743 (USD $2,359) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 24.9379 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 24.9379. The average price that HIK.L shares were previous bought at was GBP 24.4976. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 23,805 (USD $32,212) compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 34.1565 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 34.1565. The average price that DEMANT.CO shares were previous bought at was DKK 34.1992. The current market price is -0.1% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 22,695 (USD $3,464) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 90.94 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 90.94. The average price that DIA.MI shares were previous bought at was EUR 68.5775. The current market price is 32.6% higher than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 5,748 (USD $6,544) compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 63.9026 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 63.9026. The average price that NOVO-B.CO shares were previous bought at was DKK 65.9517. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 1,769,322 (USD $270,058) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 84.2651 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 84.2651. The average price that COLO-B.CO shares were previous bought at was DKK 92.5737. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 58,927 (USD $8,994) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.7382 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.7382. The average price that HLN.L shares were previous bought at was GBP 4.70903. The current market price is 0.6% higher than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 259,872 (USD $351,644) compared to the previous valuation of Haleon PLC |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 161.45 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 161.45. The average price that UCB.BR shares were previous bought at was EUR 171.449. The current market price is -5.8% lower than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 125,228 (USD $142,565) compared to the previous valuation of UCB SA however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 102.657 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 102.657. The average price that NOVN.SW shares were previous bought at was CHF 98.158. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 787,319 (USD $956,773) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 127.848 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 127.848. The average price that AZN.L shares were previous bought at was GBP 128.315. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 929,844 (USD $1,258,212) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 87.12 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 87.12. The average price that SAN.PA shares were previous bought at was EUR 95.2663. The current market price is -8.6% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 153,945 (USD $175,258) compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 17.7415 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 17.7415. The average price that GSK.L shares were previous bought at was GBP 16.7885. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 172,830 (USD $233,864) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 243.9 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 243.9. The average price that EL.PA shares were previous bought at was EUR 248.822. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 94,257 (USD $107,307) compared to the previous valuation of EssilorLuxottica SA |
| LONN.SW - | HOLD | 0 @ CHF 600.719 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 600.719. The average price that LONN.SW shares were previous bought at was CHF 584.866. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 30,306 (USD $36,829) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 75.1647 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 75.1647. The average price that ALC.SW shares were previous bought at was CHF 81.3862. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 54,036 (USD $65,666) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 508 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 508. The average price that ARGX.BR shares were previous bought at was EUR 551.897. The current market price is -8.0% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 38,714 (USD $44,074) compared to the previous valuation of Argenx SE |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 43.86 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 43.86. The average price that FRE.DE shares were previous bought at was EUR 37.9992. The current market price is 15.4% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 61,921 (USD $70,494) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 25.32 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 25.32. The average price that BAYN.DE shares were previous bought at was EUR 21.9962. The current market price is 15.1% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 140,118 (USD $159,517) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 116.3 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 116.3. The average price that MRK.DE shares were previous bought at was EUR 130.164. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 64,000 (USD $72,861) compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 45.3746 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 45.3746. The average price that SDZ.SW shares were previous bought at was CHF 40.3939. The current market price is 12.3% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 68,197 (USD $82,875) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 271.82 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 271.82. The average price that SOON.SW shares were previous bought at was CHF 291.912. The current market price is -6.9% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 64,993 (USD $78,981) compared to the previous valuation of however if the holding was sold on 2025-06-04 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 46.11 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 46.11. The average price that SHL.DE shares were previous bought at was EUR 48.2129. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 10,726 (USD $12,211) compared to the previous valuation of Siemens Healthineers AG |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -550 @ EUR 52.6 | EUR -28,930 | The ETF sold 550 shares of REC.MI on 2025-06-04. The shares were previously bought for an average price of EUR 52.548. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of EUR 29 (USD $33) The average price that the ETF previously sold REC.MI share for is EUR 51.4134 so the ETF has sold 550 shares on 2025-06-04 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -142 @ EUR 204.2 | EUR -28,996 | The ETF sold 142 shares of SRT3.DE on 2025-06-04. The shares were previously bought for an average price of EUR 220.626. The Sartorius AG shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,332 (USD $2,655) The average price that the ETF previously sold SRT3.DE share for is EUR 221.014 which is higher than the selling price of EUR 204.2 on 2025-06-04. |
| SOBI.ST - | SELL | -1,058 @ SEK 27.7967 | SEK -29,409 | The ETF sold 1058 shares of SOBI.ST on 2025-06-04. The shares were previously bought for an average price of SEK 26.9812. The shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of SEK 863 (USD $90) The average price that the ETF previously sold SOBI.ST share for is SEK 26.8025 so the ETF has sold 1058 shares on 2025-06-04 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -1,458 @ EUR 20.18 | EUR -29,422 | The ETF sold 1458 shares of PHIA.AS on 2025-06-04. The shares were previously bought for an average price of EUR 23.2154. The Koninklijke Philips NV shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 4,426 (USD $5,038) The average price that the ETF previously sold PHIA.AS share for is EUR 22.966 which is higher than the selling price of EUR 20.18 on 2025-06-04. |
| IPN.PA - Ipsen SA | SELL | -282 @ EUR 104.5 | EUR -29,469 | The ETF sold 282 shares of IPN.PA on 2025-06-04. The shares were previously bought for an average price of EUR 107.092. The Ipsen SA shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 731 (USD $832) The average price that the ETF previously sold IPN.PA share for is EUR 105.892 which is higher than the selling price of EUR 104.5 on 2025-06-04. |
| QIA.DE - QIAGEN NV | SELL | -735 @ EUR 40.325 | EUR -29,639 | The ETF sold 735 shares of QIA.DE on 2025-06-04. The shares were previously bought for an average price of EUR 37.624. The QIAGEN NV shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of EUR 1,985 (USD $2,260) The average price that the ETF previously sold QIA.DE share for is EUR 37.7139 so the ETF has sold 735 shares on 2025-06-04 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -154 @ EUR 193.7 | EUR -29,830 | The ETF sold 154 shares of DIM.PA on 2025-06-04. The shares were previously bought for an average price of EUR 190.197. The Sartorius Stedim Biotech shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of EUR 539 (USD $614) The average price that the ETF previously sold DIM.PA share for is EUR 187.102 so the ETF has sold 154 shares on 2025-06-04 at a higher price than the previous selling average. |